cysteamine has been researched along with Leukemia L5178 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antoku, S | 1 |
| Antoku, S; Hoshi, M | 1 |
2 other study(ies) available for cysteamine and Leukemia L5178
| Article | Year |
|---|---|
Protection of cultured mammalian cells by S-2-(3-aminopropylamino)ethylphosphorothioic acid(WR-2721).
Topics: Amifostine; Animals; Cells, Cultured; Cobalt Radioisotopes; Cysteamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Leukemia L5178; Leukemia, Experimental; Liver; Mercaptoethylamines; Mice; Organothiophosphorus Compounds; Radiation-Protective Agents; Time Factors; Tissue Extracts | 1983 |
Combined effects of radiosensitizers and radioprotectors on cultured mammalian cells to Co-60 gamma-rays.
Topics: Animals; Cell Survival; Cells, Cultured; Cobalt Radioisotopes; Cysteamine; DNA, Neoplasm; Glutathione; Leukemia L5178; Leukemia, Experimental; Mice; Misonidazole; Radiation-Protective Agents; Radiation-Sensitizing Agents; Thiourea | 1984 |